Evaluation of inpatient and emergency department healthcare resource utilization and costs pre- and post-nusinersen for the treatment of spinal muscular atrophy using United States claims

• Main Authors: Cong Zhu (Author), Craig Zaidman (Author), Bora Youn (Author), Angela D Paradis (Author), Stephanie Raynaud (Author), Bridget A Neville (Author), Nicole B Johnson (Author)
• Format: Book
• Published: Becaris Publishing Limited, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: Nusinersen, administered by intrathecal injection at a dose of 12 mg, is indicated across all ages for the treatment of spinal muscular atrophy (SMA). Evidence on real-world healthcare resource use (HRU) and costs among patients taking nusinersen remains limited. This study aimed to evaluate re...